When I explain my research interests to new acquaintances, I’m often asked questions like “what would you do if you met a ...

Taxidermied, locked behind plexiglass and spinning slowly on a wooden dais in the National Museum of Scotland in Edinburgh, UK, the world’s most famous ewe remains a public spectacle three decades ...

In its annual Biotech Beyond Borders report, EY projects growth to continue throughout 2026, fueled primarily by the increased volume and value of M&A and licensing deals. (Techa Tungateja/GettyImages ...

The acquisition, Weights.gg, was a sort of social network for creating and sharing artificial intelligence algorithms. By Mike Isaac Reporting from San Francisco Two years ago, technologists at OpenAI ...

In this edition of the biotech bi-weekly, read about the latest product launches – including a cell-free synthetic DNA platform, a fully automated in situ hybridization (ISH) library and an expanded ...

Biopharma companies appear to be more willing to go public after a long drought. Just this week, GLP-1 developer Kailera Therapeutics and proteomics company Alamar Biosciences launched IPO roadshows ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Here’s ...

A clone is meant to be a genetically identical copy, but an extraordinary 20-year study has shown that this isn’t, in fact, the case. It reveals that clones have lots of extra mutations and, if you ...

Countless scientists and at least a dozen high-concept sci-fi comedies over the past 30 years have speculated on the potentially degrading effect of making clones out of other clones, ad infinitum.

Marc Cummings, president and CEO of Life Science Washington, speaking at a one-day forum focused on AI-driven biotech that was held in Seattle in October 2025. (Life Science Washington Photo) Seattle ...